期刊文献+

术前输注负载供者抗原的受者未成熟树突状细胞延长移植心存活时间的实验研究 被引量:2

Recipient immature dendritic cells loaded with donor antigens prolong cardiac allograft survival
在线阅读 下载PDF
导出
摘要 目的:利用负载供者抗原的受者未成熟树突状细胞(imDC)干扰T细胞抗原间接识别途径,观察对同种异体移植心存活时间的影响。方法:用低剂量粒细胞-巨噬细胞集落刺激因子(GM-CSF)培养受者小鼠骨髓源性imDC,并在培养过程中加入供者可溶性抗原共同孵育,流式细胞术检测细胞表型,观察其在体外刺激自体T细胞增殖的能力,并于术前1周将约2.0×106个树突状细胞(DC)输入受者体内,观察其对同种异体移植心存活时间的影响。结果:受者DC可通过共同孵育的方式有效负载供者抗原,负载供者抗原的受者imDC在体外不能有效刺激自体T细胞活化增殖,将其于术前输入受者体内,移植心的存活时间由(7.2±1.7)天延长至(17.7±3.3)天。结论:术前输注负载供者抗原的受者imDC,可明显延长移植心的存活时间。 Objective:To observe the effect of recipient immature dendritic cells(DC) loaded with donor antigens on cardiac allograft survival. Methods:Recipient immature DC were generated with low doses GM-CSF and co-culture with donor antigens, the phenotype and functional properties of these DC were detected through FACS analysis and MLR. 2.0 ×10^6 recipient immature DC loaded with donor antigen were administered to the recipients 7 days before transplantation, and the cardiac allograft survival were observed. Results:Recipient DC can loaded donor antigens effectively by co-culture with them, and immature DC loaded with allogeneic antigens induced syngeneic T cell unresponsiveness, and administration of these DC to recipients prolonged cardiac allograft survival from (7.2 ± 1.7)d to (17.7 ± 3. 3 )d. Conclusion:Recipient immature DC loaded with donor antigens prolonged cardiac allograft survival when they were administered 7 days before transplantation.
出处 《医学研究生学报》 CAS 2005年第10期886-888,892,共4页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30471715)
关键词 树突状细胞 间接识别途径 心脏移植 免疫耐受 Dendritic cells Indirect allorecognition Heart transplantation Immune tolerance
作者简介 冯剑锷(1974-),男,湖北咸宁人,医师,医学博士研究生,从事心血管外科专业。
  • 相关文献

参考文献10

  • 1Mandelbrot DA,Furukawa Y,McAdam AJ,et al.Expression of B7 molecules in recipient,not donor,mice determines the survival of cardiac allografts[J].J Immunol,1999,163(7):3753-3757.
  • 2Oluwole OO,Depaz HA,Gopinathan R,et al.Indirect allorecognition in acquired thymic tolerance:induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells[J].Diabetes,2001,50(7):1546-1552.
  • 3Lutz MB,Kukutsch N,Ogilvie AL,et al.An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow[J].J Immunol Methods,1999,223(1):77-92.
  • 4Lutz MB,Suri RM,Niimi M,et al.Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo[J].Eur J Immunol,2000,30(7):1813-1822.
  • 5于哲,范清宇,张婷,刘云燕.大鼠骨髓造血干细胞体外定向诱导、扩增树突状细胞及其功能鉴定[J].医学研究生学报,2004,17(7):588-591. 被引量:10
  • 6于哲,范清宇.树突状细胞肿瘤疫苗的研究进展[J].医学研究生学报,2005,18(1):63-66. 被引量:8
  • 7Benham AM,Sawyer GJ,Fabre JW.Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts[J].Transplantation,1995,59(7):1028-1032.
  • 8Kurts C,Kosaka H,Carbone FR,et al.Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells[J].J Exp Med,1997,186(2):239-245.
  • 9Jonuleit H,Schmitt E,Schuler G,et al.Induction of interleukin 10-producing,nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells[J].J Exp Med,2000,192(9):1213-1222.
  • 10Arpinati M,Green CL,Heimfeld S,et al.Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells[J].Blood,2000,95(8):2484-2490.

二级参考文献46

  • 1[1]Eugene MK, Muthukumaran S, Christos IS et al. Adjuvant effect of a lit3 ligand (FL) gene-transduced xenogeneic cell line in a murine colon cancer model[J]. J Surg Res,2002,108( 1 ) :148-156.
  • 2[2]Ozcan M, Soen B, Mogens HC et al. Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more eftciently than protein-loaded cross-presenting DC[ J]. Cellular Immunology ,2003,222:126-133.
  • 3[3]William MS, Kristin LV, Carrie J et al. Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells [ J ]. Molecular Therapy, 2003,7(4) :498-505.
  • 4[4]Hiroshi T, Keiji S, Takashi H et al. Therapeutic immune response induced by electrofusion of dendritic and tumor cells [ J ].Cellular Immunology,2002,220: 1-12.
  • 5[6]Zeinab AW, Matthew FK, Sirisha E et al. Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amin acid substitution [ J ]. Cellular Immunology, 2003,224: 86-97.
  • 6[7]Gong JL, David A, Chen DS et al. Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells[J]. PNAS,2000,97(2) :2715-2718.
  • 7[8]Gong JL, Najmosama N, Chen DS et al. Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity [ J]. J Immunology, 2000, 165: 1705-1711.
  • 8[9]Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice [ J ]. Exp Med, 1973,137 ( 5 ):1142-1162.
  • 9[11]Hart DN, Hill GR. Dendritic cell immunotherapy for cancer: application to low grade lymphoma and multiply myeloma[ J]. Immunol Cell Biol,1999,77(5) :451-459.
  • 10[12]Markowicz S, Engleman EG. Granulocyte-macrophage colonystimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro[ J ]. J Clin Invest,1990, 85(3) :955-961.

共引文献16

同被引文献20

  • 1于哲,范清宇.树突状细胞肿瘤疫苗的研究进展[J].医学研究生学报,2005,18(1):63-66. 被引量:8
  • 2方勇,王蓓蓓,吴鹏,马晓黎,卢运萍,周剑锋,马丁.曲古抑菌素A上调肿瘤细胞柯萨奇-腺病毒受体表达而抑制其侵袭力的体外研究[J].医学研究生学报,2007,20(5):451-454. 被引量:1
  • 3Liu A,Takahashi M,Narita M,et al.Generation of functional and mature dendritic cells from cord blood and bone marrow CD34 + cells by two-step culture combined with calcium ionophone treatment[J].J Immunol Methods,2002,261 (1/2):49-63.
  • 4Rouas R,Lewalle P,Ei Ouriaqhli F,et al.Poly(I∶C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12[J].Int Immunol,2004,16 (5):767-773.
  • 5Lipscomb MF,Masten BJ.Dendritic cells:immune regulators in health and disease[J].Physiol Rev,2002,82(1):97-130.
  • 6Zhou Y,Bosch ML,Salgaller ML.Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity[J].J immunother,2002,25(4):289-303.
  • 7Jonuleit H,Schmitt E,Steinbrink K,et al.Dendritic cells as a tool to induce anergic and regulatory T cells[J].Trends Immunol,2001,22(7):394-400.
  • 8Remmel E,Terracciano L,Noppen C,et al.Modulation of dendritic cell phenotype and mobility by tumor cells in vitro[J].Hum Immunol,2001,62 (1):39 -49.
  • 9Cools N, Ponsaerts P, van Tendeloo VF, et al. Balancing be- tween immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells [ J ]. J Leukoc Biol, 2007, 82(6): 1365-1374.
  • 10Manieassamy S, Pulendran B. Dendritic cell control of tolerogen- ic responses[J]. Immunol Rev, 2011, 241 ( 1 ) : 206-227.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部